Today, the biggest bottleneck in genetic medicine isn’t the power of mRNA, CRISPR, or gene therapy—it’s that we can’t get these medicines anywhere but the liver. Our RAPTOR™ platform is the first AI-driven system that makes extrahepatic genetic medicine scalable. Unlike the slow, inefficient trial-and-error process that dominates biotech, we directly test hundreds of novel lipid nanoparticles (LNPs) in non-human primates (NHPs) at 100 times lower cost, generating real-world, human-relevant data.
Company Details
- Employees
- 8
- Founded
- 2022
- Address
- 40 Guest St, Boston,massachusetts 02135,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.liberatebio.com
- HQ
- Boston, Massachusetts
Liberate Bio Questions
Liberate Bio's website is http://www.liberatebio.com
Liberate Bio's LinkedIn profile is https://www.linkedin.com/company/liberate-bio
Liberate Bio has
8 employees.
View email and phone details for 8
employees at Liberate Bio.
Liberate Bio's industry is
Biotechnology Research
Liberate Bio's top competitors are
Everyone Medicines,
Carver Biosciences, Inc.,
Quantum-Si,
Tune Therapeutics,
Remedium Bio,
Clover Biopharmaceuticals,
Deep Genomics,
Tessera Therapeutics,
Penn Institute For Rna Innovation,
Khosla Ventures.
Liberate Bio's categories are Biotechnology Research
Liberate Bio's founding year is 2022
